NCT07098455

Brief Summary

Osteoarthritis (OA) is a degenerative disease characterized by progressive cartilage deterioration, osteophyte formation, subchondral sclerosis, and a number of biochemical and morphological changes in weight-bearing joints that are affected by genetic, mechanical, and biochemical factors. The prevalence of secondary chronic knee pain in OA is more than 12% in individuals over the age of 60. It is one of the most common musculoskeletal disorders in elderly patients and has become a global health problem. Standard treatments for OA include physical therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), tramadol, opioids, intra-articular hyaluronic acid, or steroids. In more severe cases, surgical knee arthroplasty should be considered. But long-term use of NSAIDs is associated with stomach bleeding, adverse cardiovascular events, and kidney failure. Opioids are often used, but a large number of side effects are encountered, especially in the elderly. Knee surgery is not always possible and can cause complications such as hematomas, infections, and damage to the surrounding tissue. Radiofrequency (RF) application (pulsed or continuous) is a neuromodulatory or neurolytic technique that represents an alternative in pain due to osteoarthritis. RF therapy is one of the conservative treatments that has many advantages, such as minimal invasiveness, rapid recovery, and less negative response. Radiofrequency thermocoagulation (RFT) destroys the integrity of peripheral nerves using hyperthermia and thereby blocks the transmission of pain signals, while pulsed radiofrequency (PRF) regulates neurological functions or inhibits the production of immunoinflammatory factors (e.g., IL-1β, TNF-α, IL-6) by using electric fields to affect their production, thereby relieving pain in patients. Genicular nerve radiofrequency thermocoagulation application and knee intra-articular pulsed radiofrequency application are the two radiofrequency methods routinely applied in the treatment of gonarthrosis-induced pain in our clinic. In this study, it is aimed to evaluate the effectiveness of these two methods and compare their outcomes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Aug 2025Jul 2026

First Submitted

Initial submission to the registry

July 10, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 1, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

August 21, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

January 15, 2026

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

July 10, 2025

Last Update Submit

January 13, 2026

Conditions

Keywords

Osteoarthritis of KneePulsed Radiofrequency TreatmentRadiofrequency Ablation

Outcome Measures

Primary Outcomes (1)

  • NRS

    Pain intensity was measured using an 11-point Numeric Rating Scale, where 0 indicates no pain and 10 indicates the worst pain imaginable. Patients rated their pain intensity based on their average pain during the defined time frame. Changes in NRS scores over time were used to evaluate treatment response.

    baseline, at the 3rd month

Secondary Outcomes (2)

  • GPE

    baseline, 3rd month

  • WOMAC

    baseline; 3rd month

Study Arms (2)

GNRFT - Genicular Nerve Radiofrequency Ablation

EXPERIMENTAL

Patients in this group will undergo ultrasound-guided genicular nerve radiofrequency ablation.

Procedure: GNRFT- genicular nerve radiofrequency ablation

IAPRF - Intra-articular pulsed radiofrequency

EXPERIMENTAL

KNEE INTRAARTICULAR PULSED RADIOFREQUENCY WILL BE APPLIED TO PATIENTS IN THIS GROUP

Procedure: IAPRF- Intraarticular pulsed radiofrequency

Interventions

Ultrasound-guided genicular nerve radiofrequency ablation will be performed

GNRFT - Genicular Nerve Radiofrequency Ablation

Intra-articular pulsed radiofrequency will be applied under fluoroscopy guidance.

IAPRF - Intra-articular pulsed radiofrequency

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age;
  • Patients who have pain due to knee osteoarthritis
  • Patients who agree to undergo knee geniculate nerve thermocoagulation or knee intra-articular pulsed radiofrequency therapy and follow-up.

You may not qualify if:

  • Patients using anticoagulants and those with coagulation disorders,
  • Patients with psychomotor disorders,
  • Patients who have undergone intra-articular injections, interventional procedures, or surgery for knee osteoarthritis in the last year,
  • Patients with bacterial infection or infectious discharge in the area to be treated,
  • Patients with allergies to local anesthetics, and pregnant and breastfeeding patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 10, 2025

First Posted

August 1, 2025

Study Start

August 21, 2025

Primary Completion

March 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

January 15, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations